PINK:SKYE

Skye Bioscience Stock Signals

etoro logo Buy SKYE
*Your capital is at risk
$1.40
+0.1000 (+7.69%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.705 31 days ( 26.32 % )
Last Price $1.40 7.69 %
High/ Low $1.36 - $1.46 3.68%
Chg 7 Days -1.41 % $1.42 $1.40
Chg 30 Days 1.45 % $1.38 $1.40
Chg 12 mos -71.72 % $4.95 $1.40
Trend - 3 mos -50.22 % Width: 226.48 %
Trend - 12 mos -8.19 % Width: 399.41 %
Pred. range - 3 mos $0.486 - $1.59 -65.25 % - 13.45 %
Pred. range - 12 mos $0.86 - $4.31 -38.32 % - 208.06 %
Short MA avg 3 mos Buy Nov 11, 2025 - 5 days
Long MA avg 3 mos Sell Oct 03, 2025 - 32 days
Short/Long MA avg 3 mos Sell Oct 06, 2025 - 31 days
Short MA avg 12 mos Buy Nov 11, 2025 - 5 days
Long MA avg 12 mos Sell Oct 03, 2025 - 32 days
Short/Long MA avg 12 mos Sell Oct 13, 2025 - 26 days
Pivot Short Buy Nov 14, 2025 - 2 days
Bollinger Buy Nov 14, 2025 - 2 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT SKYE BIOSCIENCE, INC.
Skye Bioscience
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degenerati...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE